Literature DB >> 7039299

Primary adenomatous neoplasms of the middle ear: light and electron microscopic features of a group distinct from the ceruminomas.

W G Riches, W H Johnston.   

Abstract

The light and electron microscopic features of two primary adenomatous neoplasms of the middle ear are presented and compared with those cases in the literature. Primary adenomatous neoplasms of the middle ear appear to be derived from the lining epithelium of the middle ear and are distinct from the cercuminomas. They exhibit benign or indolently malignant behavior. Cytologic and histologic features are bland and uniform. Invasion of adjacent soft tissues and/or bone is the only histologic feature indicative of malignancy. Distant metastasis has not been reported. The duration and nature of the symptoms are of little diagnostic value. Radiographic and/or operative evidence of bone erosion reflects the aggressive potential of these neoplasms, although its absence does not exclude microscopic invasion. The primary adenomatous neoplasms of the middle ear recur locally if incompletely excised. Radical mastoidectomies and/or complete removal through the external auditory canal are curative.

Entities:  

Mesh:

Year:  1982        PMID: 7039299     DOI: 10.1093/ajcp/77.2.153

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  3 in total

1.  Adenoma of the middle ear mucosa.

Authors:  B Arnold; C Zietz; J Muller-Hocker; T P Wustrow
Journal:  Eur Arch Otorhinolaryngol       Date:  1996       Impact factor: 2.503

2.  Ceruminous gland carcinomas: a clinicopathologic and immunophenotypic study of 17 cases.

Authors:  Nikhil Crain; Brenda L Nelson; E Leon Barnes; Lester D R Thompson
Journal:  Head Neck Pathol       Date:  2008-12-03

3.  Neuroendocrine neoplasms of the head and neck: some suggestions for the new WHO classification of head and neck tumors.

Authors:  Bin Xu; Runjan Chetty; Bayardo Perez-Ordoñez
Journal:  Head Neck Pathol       Date:  2014-03-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.